Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C

Gastroenterology

Volumn 141, Issue 4, 2011, Pages

  Ahlenstiel, Golo ^a   Edlich, Birgit ^a   Hogdal, Leah J ^a   Rotman, Yaron ^a   Noureddin, Mazen ^a   Feld, Jordan J ^a   Holz, Lauren E ^a   Titerence, Rachel H ^a   Liang, T Jake ^a   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cell Death; HCV Treatment; Liver Disease; Response to Therapy

Indexed keywords

CD16 ANTIGEN; LYMPHOCYTE RECEPTOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; PEGINTERFERON ALPHA2A; RIBAVIRIN; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ADD ON THERAPY; ADULT; ARTICLE; BLOOD; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LIVER; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 80053593363     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.069     Document Type: Article

References (30)

1. S. Ciesek, and M.P. Manns Hepatitis in 2010: the dawn of a new era in HCV therapy Nat Rev Gastroenterol Hepatol 8 2011 69 71
2. T.J. Layden, B. Mika, and T.E. Wiley Hepatitis C kinetics: mathematical modeling of viral response to therapy Semin Liver Dis 20 2000 173 183 (Pubitemid 30618715)
3. B. Rehermann Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence J Clin Invest 119 2009 1745 1754
4. S. Norris, C. Collins, and D.G. Doherty Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes J Hepatol 28 1998 84 90 (Pubitemid 28122504)
5. C.A. Biron, K.B. Nguyen, and G.C. Pien Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220 (Pubitemid 29241123)
6. S.I. Khakoo, C.L. Thio, and M.P. Martin HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874 (Pubitemid 39038423)
7. S. Knapp, U. Warshow, and D. Hegazy Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus Hepatology 51 2010 1168 1175
8. M.A. Cooper, T.A. Fehniger, and S.C. Turner Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset Blood 97 2001 3146 3151
9. C. Fauriat, E.O. Long, and H.G. Ljunggren Regulation of human NK-cell cytokine and chemokine production by target cell recognition Blood 115 2010 2167 2176
10. A. De Maria, F. Bozzano, and C. Cantoni Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation Proc Natl Acad Sci U S A 108 2011 728 732
11. A. De Maria, M. Fogli, and S. Mazza Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients Eur J Immunol 37 2007 445 455 (Pubitemid 46915584)
12. G. Ahlenstiel, R.H. Titerence, and C. Koh Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa- dependent manner Gastroenterology 138 2010 325 335
13. B. Oliviero, S. Varchetta, and E. Paudice Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160 1160 e1-7
14. C. Dunn, M. Brunetto, and G. Reynolds Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage J Exp Med 204 2007 667 680 (Pubitemid 46457088)
15. K.A. Stegmann, N.K. Bjorkstrom, and H. Veber Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection Gastroenterology 138 2010 1885 1897
16. J.J. Feld, A.A. Modi, and R. El-Diwany S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders Gastroenterology 140 2011 830 839
17. G. Ahlenstiel, M.P. Martin, and X. Gao Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses J Clin Invest 118 2008 1017 1026 (Pubitemid 351364609)
18. G. Parruti, E. Polilli, and F. Sozio Rapid prediction of sustained virological response in patients chronically infected with HCV by evaluation of RNA decay 48h after the start of treatment with pegylated interferon and ribavirin Antiviral Res 88 2010 124 127
19. L. Golden-Mason, A.L. Cox, and J.A. Randall Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro Hepatology 52 2010 1581 1589
20. D. Sene, F. Levasseur, and M. Abel Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines PLoS Pathog 6 2010 e1001184
21. J. Nattermann, H.D. Nisschalke, and V. Hofmeister The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells Am J Pathol 166 2005 443 453 (Pubitemid 40189041)
22. R.J. Harrison, A. Ettorre, and A.M. Little Association of NKG2A with treatment for chronic hepatitis C virus infection Clin Exp Immunol 161 2010 306 314
23. L. Lan, S. Gorke, and S.J. Rau Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner J Immunol 181 2008 4926 4935
24. P. Bonorino, M. Ramzan, and X. Camous Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C J Hepatol 51 2009 458 467
25. O. Dessouki, Y. Kamiya, and H. Nagahama Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment Biochem Biophys Res Commun 393 2010 331 337
26. T. Miyagi, T. Takehara, and K. Nishio Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection J Hepatol 53 2010 424 430
27. S. Lee, M.W. Watson, and J.P. Flexman Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy J Med Virol 82 2010 568 574
28. K. Witte, G. Gruetz, and H.D. Volk Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines Genes Immun 10 2009 702 714
29. M.M. Dring, M.H. Morrison, and B.P. McSharry Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection Proc Natl Acad Sci U S A 108 2011 5736 5741
30. E. Vivier, D.H. Raulet, and A. Moretta Innate or adaptive immunity? The example of natural killer cells Science 331 2011 44 49